moxifloxacin has been researched along with ketorolac tromethamine in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (ketorolac tromethamine) | Trials (ketorolac tromethamine) | Recent Studies (post-2010) (ketorolac tromethamine) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 650 | 249 | 152 |
| Protein | Taxonomy | moxifloxacin (IC50) | ketorolac tromethamine (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 2.7 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pawar, P; Salvi, V | 1 |
1 other study(ies) available for moxifloxacin and ketorolac tromethamine
| Article | Year |
|---|---|
Eudragit RL100 Based Moxifloxacin Hydrochloride and Ketorolac Tromethamine Combination Nanoparticulate System for Ocular Drug Delivery.
Topics: Acrylic Resins; Animals; Anti-Bacterial Agents; Chemical Precipitation; Cornea; Drug Compounding; Drug Liberation; Drug Therapy, Combination; Goats; Ketorolac Tromethamine; Moxifloxacin; Nanoparticles; Ophthalmic Solutions; Particle Size | 2020 |